Omega 3: EPA+DPA+DHA (percent of total fatty acids)

Cardiovascular

About Omega 3: EPA+DPA+DHA

Omega-3 fatty acids, specifically Eicosapentaenoic acid (EPA), Docosapentaenoic acid (DPA), and Docosahexaenoic acid (DHA), are essential fats with potent anti-inflammatory properties. They are crucial for brain function, cardiovascular health, and reducing inflammation in the body. These long-chain polyunsaturated fats are primarily found in fish oils and some marine organisms. They play a significant role in cellular membrane fluidity and signaling pathways.

Reference Values

Optimal Range
8.0 - 14.0 percent of total fatty acids
Elite Value
14.0 percent of total fatty acids

Health Implications

High
Elevated levels may indicate an imbalance that could contribute to increased bleeding risk or immune dysfunction.
Low
Low levels may be associated with heightened inflammation, cardiovascular issues, and impacts on cognitive functions.

Symptoms

High
May include bloating, nausea, diarrhea, and gastrointestinal discomfort.
Low
Can include fatigue, poor concentration, dry skin, and joint pain.

Lifestyle Factors

Increase consumption of fatty fish Include flaxseeds and walnuts in diet Reduce intake of trans fats Supplement with high-quality fish oil Limit consumption of industrial seed oils

Specimen Type

Whole Blood Red Blood Cells Blood Plasma Blood Serum

Testing Methods

Blood Test Fingerstick Test Dried Blood Spot Plasma Levels Red Blood Cell Analysis
Also Known As
Omega-3 fatty acidsEicosapentaenoic acid (EPA)Docosahexaenoic acid (DHA)Dihomogamma-linolenic acid (DPA)

Scientific Sources

  1. Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., Tardif, J. C., & Ballantyne, C. M. (2019). Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. *New England Journal of Medicine*, 380(1), 11-22.
  2. Manson, J. E., Cook, N. R., Lee, I. M., Christen, W., Bassuk, S. S., Mora, S., Gibson, H., Albert, C. M., Gordon, D., Copeland, T., D'Agostino, D., Friedenberg, G., Ridge, C., Bubes, V., Giovannucci, E. L., Willett, W. C., & Buring, J. E. (2019). Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer. *New England Journal of Medicine*, 380(1), 23-32.
  3. Nicholls, S. J., Lincoff, A. M., Garcia, M., Bash, D., Ballantyne, C. M., Barter, P. J., Davidson, M. H., Kastelein, J. J. P., Koenig, W., McGuire, D. K., Mozaffarian, D., Ridker, P. M., Ray, K. K., Stroes, E. S., Lopez, J. A. G., & Wolski, K. (2020). Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. *JAMA*, 324(22), 2268-2280.
  4. American Heart Association. (2019). Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association. *Circulation*, 140(12), e673-e691.
  5. Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H. O., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., Song, F., & Hooper, L. (2020). Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. *Cochrane Database of Systematic Reviews*, 3, CD003177.

Testing Information

Looking to get your Omega 3: EPA+DPA+DHA tested? Find labs near you that offer this test.

Find Testing Locations